Clinical Trial Update: Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating Viralym-M (ALVR105) for virus-associated hemorrhagic cystitis, including BK virus infection, was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bk Virus Infection
• Hemorrhagic Cystitis

Drugs mentioned

• Viralym-M (ALVR105)

Snippet

Sponsor: AlloVir | Conditions: BK Virus Infection, Hemorrhagic Cystitis | Phase 3 | Status: TERMINATED | Results posted: 2024-05-14